Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If this is old news I missed it - quote from Alliacense VP

If this is old news I missed it - quote from Alliacense VP

posted on Nov 02, 2007 09:59AM

http://www.businesswireindia.com/Feeds/HT/bwirelease14176.asp

NovĀ 2 2007 Business Wire:

Andre-Pascal Chauvin, Vice President, Licensing for Alliacense -

"It's pretty common to see the pace of deals pick up as trial approaches," said Mike Davis, Sr. Vice President, Licensing. "A number of companies that have been following the case closely needed a little time to evaluate the recent Markman ruling, and are now moving to capture licenses at current prices and avoid significantly higher royalty rates following trial."

Share
New Message
Please login to post a reply